Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis

This study has been terminated.
(An interim analysis showed that nitric oxide patches are not enough effective)
Sponsor:
Collaborators:
Universidad de Antioquia
The University of Akron
Universidad de Santander
Secretaria de Salud de Santander
Secretaria de Salud de Tolima
Information provided by:
Fundación Cardiovascular de Colombia
ClinicalTrials.gov Identifier:
NCT00317629
First received: April 21, 2006
Last updated: November 23, 2010
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2009
  Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)